Accurate, robust and reliable calculations of

Poisson-Boltzmann binding energies

Duc D. Nguyen,†,§ Bao Wang,†,§ and Guo-Wei Wei∗,†,‡,¶

Department of Mathematics

Michigan State University, MI 48824, USA, Department of Electrical and Computer Engineering

Michigan State University, MI 48824, USA, and Department of Biochemistry and Molecular

Biology

Michigan State University, MI 48824, USA

E-mail: wei@math.msu.edu

Abstract

Poisson-Boltzmann (PB) model is one of the most popular implicit solvent models in bio-

physical modeling and computation. The ability of providing accurate and reliable PB es-

timation of electrostatic solvation free energy, ∆Gel, and binding free energy, ∆∆Gel, is of

6
1
0
2

 
r
a

M
 
3
1

 
 
]

.

M
B
o
i
b
-
q
[
 
 

1
v
4
5
0
4
0

.

3
0
6
1
:
v
i
X
r
a

∗To whom correspondence should be addressed
†Department of Mathematics

Michigan State University, MI 48824, USA

‡Department of Electrical and Computer Engineering

Michigan State University, MI 48824, USA

¶Department of Biochemistry and Molecular Biology

Michigan State University, MI 48824, USA

§The ﬁrst two authors contribute equally to this work

1

tremendous signiﬁcance to computational biophysics and biochemistry. Recently, it has been

warned in the literature (Journal of Chemical Theory and Computation 2013, 9, 3677-3685)

that the widely used grid spacing of 0.5Å produces unacceptable errors in ∆∆Gel estimation

with the solvent exclude surface (SES). In this work, we investigate the grid dependence of

our PB solver (MIBPB) with SESs for estimating both electrostatic solvation free energies and

electrostatic binding free energies. It is found that the relative absolute error of ∆Gel obtained
at the grid spacing of 1.0Å compared to ∆Gel at 0.2Å averaged over 153 molecules is less than

0.2%. Our results indicate that the use of grid spacing 0.6Å ensures accuracy and reliability in

∆∆Gel calculation. In fact, the grid spacing of 1.1Å appears to deliver adequate accuracy for

high throughput screening.

2

1

Introduction

Electrostatics is ubiquitous in biomolecular and cellular systems and of paramount importance to

biological processes. Accurate and reliable prediction of electrostatic binding free energy, ∆∆Gel,
is crucial to biophysical modeling and computation. The prediction of ∆∆Gel plays a vital role
in the study of many cellular processes, such as signal transduction, gene expression, and protein

synthesis. Additionally, many pharmaceutical applications, specially in the ﬁnal stage of the drug

design, rely on the accurate and reliable calculation of binding free energy. Technically, the accu-

racy and reliability of electrostatic binding energy prediction depend essentially on the quality of

electrostatic solvation (∆Gel) estimation, which can be achieved by solving the Poisson-Boltzmann
(PB) equation in the implicit solvent model.1–5 In past decades, the development of a robust PB

solver catches much attention in computational biophysics and biochemistry. Mathematically, most

PB solvers reported in the literature are based on three major approaches, namely, the ﬁnite dif-

ference method (FDM),6 the ﬁnite element method (FEM),7 and the boundary element method

(BEM).8,9 Among them, the FDM is prevalently used in the ﬁeld due to its simplicity in imple-

mentation. The emblematic solvers in this category are Amber PBSA,10,11 Delphi,12,13 APBS14

and CHARMM PBEQ.6

Recently, it has been warned that “the widely used grid spacing of 0.5 Å produces unaccept-
able errors in ∆∆Gel”.15 Although all results were obtained with the adaptive Cartesian grid (ACG)
ﬁnite difference PB equation solver, the authors speculated that the same applies to all other PB

solvers. Therefore, this study has arisen serious concerns about the validity of using PB model

for biomolecular electrostatic binding analysis. In this work, we investigate the grid dependence

of our PB solver (MIBPB)16,17 in estimating both electrostatic solvation free energies and electro-

static binding free energies. The MIBPB solver is by far the only existing second-order accurate

method for solving the Poisson-Boltzmann equation with discontinuous dielectric constants, sin-

gular charge sources, and geometric singularities from the solvent excluded surfaces (SESs) of

biomolecules.16 Contrary to the ﬁndings in the literature,15 our results indicate that the use of grid

spacing 0.6 Å ensures accuracy and reliability in ∆∆Gel calculation. In fact, a grid spacing of 1.1

3

Å appears to deliver adequate accuracy for high throughput screening. We therefore believe that

when it is used properly, the PB methodology is able to deliver accurate and reliable electrostatic

binding analysis.

2 Methods

2.1 MIBPB package

In the current work, we employ the our MIBPB package16,17 to predict the electrostatic solvation

free energy. The MIBPB package is a second-order convergence PB solver for dealing with the

SESs of biomolecules. Numerically, there are three major obstacles in constructing accurate and

reliable PB solvers. First, commonly used solvent-solute interfaces, i.e., the van der Walls (vdW)

surface, solvent accessible surface (SAS), and the solvent excluded surface (SES)18,19 admit ge-

ometric singularities, such as sharp tips, cusps and self-intersecting surfaces,20 which make the

rigorous enforcement of interface jump conditions a formidable task in PB solvers. An advanced

mathematical interface techniques, the matched interface and boundary (MIB) method,21–23 is em-

ployed in the MIBPB package to achieve the second order accuracy in handling biomolecular SESs.

Additionally, the atomic singular charges described by the delta functions give rise to another difﬁ-

culty in constructing highly accurate PB solver. A Dirichlet-to-Neumann map technique has been

developed in the MIBPB package to avoid the numerical approximation of singular charges by

using the analytical Green’s functions.24 Finally, the nonlinear Boltzmann term can affect solver

efﬁciency when handled inappropriately, particularly for BEMs. A quasi-Newton algorithm is im-

plemented in the MIBPB package16 to take care the nonlinear term.16 Our recent effort has made

our MIBPB package more robust, accurate and reliable.17

4

2.2 Interface generation

Many studies suggest that SES is able to deliver the state of the art accurate modeling of the sol-

vated molecule.7,9,13 As a result, much effort has been paid to developing an accurate and robust

SES software.20,25 However, the MSMS software20 generates a Lagrangian representation of the

SES and is inconvenient for the Cartesian domain implementation of PB solvers. A Lagrangian

to Eulerian transformation is required to convert MSMS surfaces for our Cartesian based MIBPB

solver.4 Most recently, we have developed a new SES software, Eulerian solvent excluded sur-

face (ESES), to directly generate the SESs in the Eulerian representation.26 Our ESES software

enables the MIBPB solver to produce a reliable ∆Gel. Both MSMS and ESES are supported by
our MIBPB software.17 By increasing the MSMS surface density, the electrostatic solvation free

energies calculated by using MSMS converge to those obtained by using ESES.26 Therefore, only

results employing ESES are shown in this work.

2.3 Data sets

In the present work, we adopt three sets of biomolecular complexes employed in the literature15

for solvation free energy and binding free energy estimations. Speciﬁcally, the ﬁrst set, Data

Set 1, is a collection of DNA-minor groove drug complexes having a narrow range of ∆∆G.

The Protein Data Bank (PDB) IDs (PDBIDs) for this set are as follows: 102d, 109d, 121d,

127d, 129d, 166d, 195d, 1d30, 1d63, 1d64, 1d86, 1dne, 1eel, 1fmq, 1fms, 1jtl, 1lex, 1prp,

227d, 261d, 164d, 289d, 298d, 2dbe, 302d, 311d, 328d, and 360d. The second set, Data Set

2, includes various wild-type and mutant barnase-barstar complexes.

Its PDBIDs are as fol-

lows: 1b27, 1b2s, 1b2u, 1b3s, 2aza4, 1x1w, 1x1y, 1x1u, and 1x1x. In the last set, Data Set 3,

we investigate RNA-peptide complexes with following PDBIDs: 1a1t, 1a4t, 1biv, 1exy, 1g70,

1hji, 1i9f, 1mnb, 1nyb, 1qfq, 1ull, 1zbn, 2a9x, and 484d. The detail of the structural prepos-

sessing can be found in Ref. Harris et al.. The data sets can be downloaded from website

http://www.sb.fsu.edu/˜mfenley/convergence/downloads/convergence_pqr_sets.tar.gz. They are also

available from the present authors upon request.

5

2.4 Poisson-Boltzmann calculation details

The electrostatics binding free energy is a measure of binding afﬁnity of two compounds due to

the electrostatics interaction. Based on the free energy cycle, the electrostatics binding free energy

can be calculated by the following formula27

∆∆Gel = (∆Gel)AB − (∆Gel)A − (∆Gel)B + (∆∆Gel)Coulomb ,

(1)

where (∆Gel)AB is the electrostatic solvation free energy of the bounded complex AB, (∆Gel)A and
(∆Gel)B are the electrostatic solvation free energies of the unbounded components A and B, and
(∆∆Gel)Coulomb is the electrostatic binding free energy of the two components in vacuum.

The electrostatic solvation free energies ∆Gel are obtained by using MIBPB software16,17 while

the binding energy (∆∆Gel)Coulomb is easily evaluated analytically via the following formula

(∆∆Gel)Coulomb = ∑

i, j

qiq j
εmri j

, ∀i ∈ A, j ∈ B,

(2)

where qi and q j are the corresponding charges of the given pair of atoms, and ri j is the distance be-
tween this pair. Here, εm is the dielectric constant of the solute region. Table 5 lists (∆∆Gel)Coulomb
values of 51 studied complexes.

In all our calculations, the absolute temperature of the ionic solvent is chosen to be T = 298 K,

the dielectric constants for solute and solvent are 1 and 80, and the ionic strength is 0.1 M NaCl.

The PBE is solved by the linearized solver, but the nonlinear one does not produce any notably

differences. The incomplete LU biconjugate gradient squared (ILUBGS) solver is employed to

solve all linear systems risen by the MIBPB approach. To maintain consistent computations of

the PB solver at different grid sizes, the criteria convergence of ILUBGS solver measured by L2-
norm is set to be 10−6, and the maximum iteration number is set to 100,000. The predictions of
MIBPB solver on ∆Gel and ∆∆Gel are conﬁrmed by other solvers such as PBSA,10,11 Delphi,12,13
and APBS14 at the grid size of 0.2 Å (results not shown here).

6

(a) PDBID: 121d

(b) PDBID: 1b3s

(c) PDBID: 1biv

Figure 1: Illustration of surface electrostatic potentials (in units of kcal/mol/e) for three complexes,
generated by Chimera software.28 (a) PDBID: 121d (in Drug-DNA complexes); (b) PDBID: 1b3s
(in barnase-barstar complexes); (c) PDBID: 1biv (in RNA-peptide complexes).

3 Results and discussion

As described above, we consider three sets of binding complexes, namely, drug-DNA, barnase-

barstar and RNA-peptide systems. For the sake of illustration, three sample surface electrostatic

potentials, each from one distinct set, are depicted in Fig. 1. PDBIDs for these three complexes

are respectively 121d (in Drug-DNA complexes), 1b3s (in barnase-barstar complexes), and 1biv

(in RNA-peptide complexes). In the rest of this section, we explore the inﬂuence of grid spacing

in Poisson-Boltzmann equation solvation and binding free energy estimations using our MIBPB

solver.

3.1 The inﬂuence of grid spacing in ∆Gel estimation

We ﬁrst examine the accurate and robustness of our MIBPB solver in predicting the electrostatic

solvation free energies of the aforementioned three data sets. Some previous literature29,30 has

recognized that a grid size of h = 0.5Å is small enough to produce a reliable ∆Gel. Such an
observation certainly remains for the MIBPB solver. In fact, our PB solver is able to deliver a very

well-convergent calculations of electrostatic solvation free energies at as coarse grid sizes as 1.0Å

7

and 1.1Å.

In the current calculations, the ﬁnest grid size is chosen to be 0.2Å, and the coarser grid sizes

are between 0.3Å and 1.1Å. Figure 2 depicts the correlations of ∆Gel at various meshes for all
complexes and unbounded components of three data sets. The electrostatic solvation free ener-

gies obtained at the ﬁnest grid spacing of 0.2Å are plotted against those computed from coarser

grid spacings of 0.3Å, 0.7Å and 1.1Å. Obviously, the best ﬁtting lines for these data at var-

ious coarse grid spacings produce near perfect alignments between the ﬁnest mesh results and

those from coarse meshes. As shown in Table 1, R2 and slope values at the pair of grid sizes

(0.2Å,1.1Å) for DNA-drug, barnase-barstar and RNA-peptide are, respectively, (1.0000,1.0004),

(0.9997,0.9972), and (1.0000,1.0005). These results indicate the accuracy and robustness in the

MIBPB prediction of electrostatic solvation free energies (∆Gel). Table 2 reports the values ∆Gel
for all the 51 complexes and associated 102 components studied in this work. Finally, we examine

the performance of our solver by considering the relative absolute error, the difference between

results obtained with coarser and the ﬁnest grid spacings, deﬁned as follows

Relative absolute error .
=

(3)

(cid:12)(cid:12)(cid:12)(cid:12)∆Gel,h − ∆Gel,h=0.2

∆Gel,h=0.2

(cid:12)(cid:12)(cid:12)(cid:12) .

Figure 3 illustrates the averaged relative absolute errors, i.e., the average of relative absolute

errors designated in Eq. (??) over all the 153 discussed molecules, at different mesh sizes. It can be

seen from Fig. 3 that the averaged relative absolute errors at all studied cases are less than 0.31%,

and for any grid spacing smaller than 1.1Å, these errors are always below 0.2%. This behavior

further indicates the grid size independence of our PB solver over the normal grid-size range in

molecular biophysical applications.

Table 2: Electrostatic solvation free energies (in units of kcal/mol), ∆Gel, for all of the 51 com-
plexes and their 102 unbounded components used in this study at different grid sizes.

DNA-drug

complexes

102d

DNA

Drug

109d

1.1Å

-5223.85

-6231.93

-147.75

1.0Å

-5218.83

-6226.33

-149.38

0.9Å

-5217.79

-6224.53

-148.37

0.8Å

-5217.09

-6224.24

-149.24

0.7Å

-5217.20

-6224.66

-149.13

0.6Å

-5215.82

-6223.50

-149.46

0.5Å

-5216.63

-6224.24

-149.30

0.4Å

-5216.67

-6224.22

-149.28

0.3Å

-5217.02

-6224.48

-149.26

0.2Å

-5217.13

-6224.56

-149.26

-5757.07

-5753.29

-5751.37

-5753.90

-5753.80

-5754.82

-5755.28

-5755.56

-5755.46

-5755.49

8

complexes

1.1Å

1.0Å

0.9Å

0.8Å

0.7Å

0.6Å

0.5Å

0.4Å

0.3Å

0.2Å

Table 2 – continued from previous page

DNA

Drug

121d

DNA

Drug

127d

DNA

Drug

129d

DNA

Drug

166d

DNA

Drug

195d

DNA

Drug

1d30

DNA

Drug

1d63

DNA

Drug

1d64

DNA

Drug

1d86

DNA

Drug

1dne

DNA

Drug

1eel

DNA

Drug

1fmq

DNA

Drug

1fms

DNA

Drug

1jtl

DNA

Drug

1lex

DNA

Drug

1prp

DNA

Drug

227d

DNA

Drug

261d

-6310.18

-6306.07

-6304.93

-6307.56

-6306.83

-6308.06

-6308.59

-6308.92

-6308.92

-6308.84

-74.31

-5226.44

-6233.35

-172.35

-5650.74

-6178.15

-80.46

-5636.29

-6180.75

-78.29

-5203.93

-6196.07

-144.15

-5199.46

-6180.63

-177.82

-5185.62

-6170.07

-176.87

-5195.78

-6192.26

-175.91

-5184.94

-6174.66

-145.25

-5223.51

-6231.45

-181.45

-5177.86

-6196.87

-174.40

-5159.67

-6162.83

-134.57

-5164.24

-6155.78

-131.07

-5176.49

-6197.26

-131.19

-4124.55

-4548.65

-97.07

-5197.65

-6193.02

-181.07

-5195.31

-6197.42

-148.65

-5199.66

-6199.66

-168.27

-73.21

-5216.29

-6223.10

-172.49

-5652.62

-6181.18

-80.51

-5639.17

-6185.07

-79.50

-5203.41

-6196.34

-144.92

-5205.72

-6188.99

-176.71

-5189.64

-6171.94

-177.76

-5197.51

-6194.59

-172.63

-5183.28

-6174.02

-143.36

-5226.18

-6232.28

-181.45

-5179.85

-6198.31

-175.42

-5165.72

-6168.65

-135.15

-5154.35

-6146.45

-131.56

-5175.03

-6195.29

-130.76

-4126.92

-4550.27

-97.19

-5201.86

-6195.25

-179.95

-5205.75

-6208.15

-148.99

-5202.58

-6201.94

-167.42

-72.55

-5222.20

-6228.20

-173.11

-5649.67

-6178.60

-79.79

-5643.64

-6189.31

-79.42

-5202.09

-6193.59

-143.72

-5201.51

-6183.59

-176.97

-5180.71

-6166.90

-174.57

-5204.87

-6196.92

-171.91

-5187.19

-6177.32

-144.12

-5226.11

-6231.50

-181.13

-5180.21

-6198.86

-174.82

-5167.50

-6170.67

-132.79

-5156.44

-6148.20

-132.78

-5177.43

-6197.47

-130.01

-4130.17

-4553.94

-97.58

-5205.15

-6198.51

-179.40

-5203.98

-6205.85

-148.37

-5199.06

-6197.94

-169.07

-73.87

-5215.67

-6221.72

-173.31

-5649.90

-6178.38

-80.68

-5643.13

-6188.62

-78.71

-5200.07

-6191.88

-144.37

-5204.07

-6186.77

-176.18

-5184.95

-6170.00

-174.31

-5202.06

-6198.02

-173.48

-5188.00

-6177.83

-144.19

-5226.35

-6231.43

-182.82

-5181.38

-6200.13

-175.32

-5166.63

-6170.27

-132.20

-5158.81

-6151.57

-132.22

-5175.86

-6197.02

-128.24

-4125.86

-4549.63

-97.25

-5203.21

-6196.95

-178.67

-5206.33

-6207.18

-149.49

-5203.89

-6201.99

-167.68

-73.41

-5217.70

-6223.72

-172.13

-5651.62

-6179.50

-81.27

-5644.34

-6190.31

-78.72

-5203.85

-6195.65

-144.36

-5202.73

-6184.56

-177.19

-5185.75

-6170.10

-175.96

-5200.47

-6195.38

-174.04

-5187.78

-6178.16

-144.47

-5224.64

-6229.99

-181.71

-5179.06

-6197.71

-174.98

-5166.04

-6169.11

-132.72

-5159.77

-6152.09

-133.21

-5178.78

-6199.48

-129.59

-4127.76

-4551.22

-97.39

-5204.31

-6197.85

-178.17

-5201.61

-6202.84

-149.24

-5198.55

-6199.07

-166.94

-72.64

-5218.97

-6225.38

-172.55

-5651.52

-6179.61

-81.11

-5644.71

-6190.81

-78.97

-5202.85

-6195.04

-144.55

-5204.97

-6186.65

-177.34

-5186.32

-6171.03

-175.46

-5199.19

-6194.26

-173.05

-5188.35

-6178.37

-144.21

-5226.47

-6231.89

-182.17

-5181.09

-6199.85

-175.01

-5169.21

-6172.18

-132.65

-5160.76

-6153.07

-133.04

-5179.37

-6199.95

-130.23

-4127.57

-4551.13

-97.27

-5203.23

-6197.10

-178.84

-5205.36

-6207.22

-149.15

-5202.57

-6202.00

-167.72

-73.16

-5219.69

-6226.32

-172.78

-5652.17

-6180.42

-81.29

-5645.73

-6191.91

-79.03

-5203.21

-6195.30

-144.63

-5205.48

-6187.27

-177.09

-5186.32

-6171.10

-175.67

-5199.81

-6195.36

-173.43

-5188.54

-6178.80

-144.24

-5227.34

-6232.57

-182.18

-5180.22

-6198.89

-175.06

-5169.95

-6172.66

-133.39

-5160.73

-6153.05

-133.24

-5179.56

-6200.36

-129.90

-4128.47

-4552.20

-97.19

-5204.92

-6198.52

-179.18

-5205.00

-6206.73

-149.28

-5201.96

-6201.45

-168.30

-73.14

-5219.96

-6226.56

-172.65

-5652.33

-6180.53

-81.23

-5645.62

-6191.82

-79.12

-5203.77

-6195.90

-144.74

-5206.02

-6187.78

-177.18

-5186.75

-6171.65

-175.90

-5199.69

-6195.53

-173.33

-5188.31

-6178.57

-144.30

-5227.58

-6232.69

-182.35

-5180.55

-6199.11

-175.33

-5170.46

-6173.22

-133.11

-5161.43

-6153.79

-133.26

-5180.23

-6200.87

-129.99

-4128.90

-4552.53

-97.20

-5205.29

-6198.95

-179.01

-5205.04

-6206.67

-149.32

-5202.54

-6202.08

-168.20

-73.17

-5220.04

-6226.59

-172.72

-5652.46

-6180.63

-81.22

-5645.53

-6191.76

-79.14

-5203.99

-6196.16

-144.75

-5206.17

-6187.95

-177.19

-5186.92

-6171.80

-175.70

-5199.98

-6195.75

-173.45

-5188.72

-6178.95

-144.35

-5227.64

-6232.80

-182.36

-5181.00

-6199.65

-175.33

-5170.09

-6172.93

-133.33

-5161.14

-6153.42

-133.34

-5180.02

-6200.69

-129.92

-4128.90

-4552.56

-97.30

-5205.88

-6199.52

-179.03

-5205.16

-6206.82

-149.41

-5202.81

-6202.24

-168.02

-73.18

-5220.03

-6226.54

-172.73

-5652.51

-6180.68

-81.22

-5645.53

-6191.79

-79.15

-5204.17

-6196.30

-144.79

-5206.34

-6188.08

-177.24

-5186.94

-6171.85

-175.73

-5200.03

-6195.86

-173.44

-5188.76

-6178.96

-144.37

-5227.54

-6232.69

-182.41

-5181.06

-6199.64

-175.38

-5170.18

-6172.98

-133.29

-5161.27

-6153.53

-133.37

-5180.13

-6200.77

-129.98

-4129.01

-4552.71

-97.30

-5205.90

-6199.58

-178.99

-5205.19

-6206.86

-149.40

-5202.86

-6202.34

-168.09

-3415.84

-3406.57

-3410.97

-3407.36

-3407.89

-3411.23

-3410.93

-3411.08

-3410.82

-3410.85

9

complexes

1.1Å

1.0Å

0.9Å

0.8Å

0.7Å

0.6Å

0.5Å

0.4Å

0.3Å

0.2Å

Table 2 – continued from previous page

Barnase-barstar

DNA

Drug

264d

DNA

Drug

289d

DNA

Drug

298d

DNA

Drug

2dbe

DNA

Drug

302d

DNA

Drug

311d

DNA

Drug

328d

DNA

Drug

360d

DNA

Drug

1b27

Barnase

Barstar

1b2s

Barnase

Barstar

1b2u

Barnase

Barstar

1b3s

Barnase

Barstar

1x1u

Barnase

Barstar

1x1w

Barnase

Barstar

1x1x

Barnase

Barstar

1x1y

Barnase

Barstar

2za4

Barnase

Barstar

RNA-peptide

1a1t

-4259.35

-4252.00

-4255.50

-4251.85

-4253.11

-4256.12

-4256.26

-4256.16

-4255.94

-4255.99

-169.83

-5694.16

-6206.81

-81.33

-5176.79

-6174.20

-139.44

-5183.86

-6167.98

-134.37

-5232.43

-6209.27

-177.20

-5661.32

-6185.99

-78.30

-5205.72

-6202.52

-176.18

-5228.77

-6199.25

-130.49

-5198.68

-6199.25

-141.42

-2265.63

-1277.09

-1575.68

-2474.57

-1212.19

-1620.62

-2381.65

-1251.26

-1438.84

-2295.38

-1301.69

-1590.33

-2268.21

-1302.89

-1578.98

-2075.69

-1244.50

-1371.67

-2193.73

-1281.37

-1419.63

-2073.97

-1242.05

-1315.93

-2196.76

-1203.33

-1369.51

-3347.00

-169.00

-5693.06

-6206.32

-79.43

-5176.64

-6176.23

-137.65

-5184.02

-6168.62

-138.18

-5223.27

-6205.34

-173.55

-5659.02

-6183.78

-80.15

-5208.47

-6198.51

-174.54

-5224.51

-6194.37

-133.07

-5194.21

-6194.37

-142.14

-2261.48

-1270.97

-1573.93

-2474.30

-1214.08

-1616.99

-2402.19

-1261.67

-1439.39

-2273.90

-1286.82

-1591.89

-2268.25

-1305.59

-1581.43

-2083.51

-1250.22

-1371.06

-2184.34

-1283.04

-1403.18

-2071.36

-1261.56

-1314.67

-2190.16

-1190.04

-1372.93

-3354.79

-168.65

-5694.65

-6208.07

-78.49

-5179.29

-6179.27

-139.49

-5184.89

-6169.47

-137.07

-5224.50

-6206.35

-172.20

-5661.41

-6186.81

-79.20

-5209.93

-6203.58

-174.72

-5224.32

-6196.88

-131.54

-5195.25

-6196.88

-142.58

-2249.30

-1271.87

-1573.17

-2479.25

-1215.08

-1623.42

-2395.23

-1260.61

-1431.88

-2284.82

-1294.61

-1588.05

-2259.77

-1305.77

-1580.44

-2074.26

-1250.89

-1372.36

-2182.99

-1283.97

-1400.95

-2063.87

-1260.57

-1309.84

-2186.92

-1190.15

-1369.36

-3352.63

-168.81

-5696.51

-6210.00

-78.94

-5179.78

-6179.17

-138.71

-5185.63

-6170.60

-136.74

-5225.68

-6208.78

-172.97

-5661.51

-6186.53

-79.62

-5205.61

-6201.54

-176.41

-5223.56

-6196.02

-131.05

-5194.99

-6196.02

-141.93

-2258.87

-1271.02

-1575.24

-2471.67

-1210.77

-1621.37

-2392.59

-1255.31

-1435.05

-2286.62

-1293.42

-1591.30

-2251.22

-1301.85

-1578.84

-2071.14

-1243.41

-1372.24

-2179.89

-1285.50

-1399.38

-2066.47

-1256.49

-1314.59

-2185.86

-1188.23

-1372.03

-3355.22

-168.49

-5695.83

-6208.89

-78.11

-5177.18

-6176.43

-138.98

-5187.44

-6171.81

-138.36

-5223.52

-6207.07

-173.15

-5659.49

-6184.80

-79.87

-5204.95

-6200.79

-175.10

-5224.55

-6197.68

-131.44

-5196.17

-6197.68

-140.66

-2262.86

-1268.82

-1576.86

-2470.55

-1211.77

-1620.97

-2391.18

-1256.67

-1435.28

-2286.62

-1292.69

-1588.18

-2254.00

-1304.50

-1576.48

-2071.68

-1243.30

-1371.91

-2183.43

-1284.87

-1402.23

-2065.45

-1260.59

-1311.99

-2191.75

-1191.09

-1372.41

-3354.98

10

-169.33

-5697.53

-6211.27

-78.57

-5179.46

-6178.39

-138.81

-5185.37

-6169.61

-137.48

-5225.68

-6209.49

-172.52

-5661.41

-6186.40

-79.70

-5207.32

-6201.61

-175.10

-5226.20

-6198.50

-131.56

-5197.30

-6198.50

-140.94

-2258.50

-1271.83

-1576.41

-2474.38

-1213.70

-1622.59

-2393.74

-1256.00

-1437.57

-2286.85

-1291.90

-1591.35

-2255.75

-1303.57

-1580.65

-2074.57

-1245.08

-1372.90

-2180.54

-1286.13

-1400.34

-2068.10

-1257.29

-1314.79

-2188.05

-1190.00

-1373.22

-3356.65

-169.07

-5697.98

-6211.70

-78.69

-5180.37

-6179.51

-138.61

-5185.82

-6170.53

-137.51

-5226.86

-6210.39

-172.79

-5662.00

-6186.92

-79.64

-5207.84

-6202.11

-175.93

-5225.95

-6198.65

-131.86

-5197.46

-6198.65

-141.83

-2261.92

-1271.75

-1577.86

-2475.32

-1214.76

-1623.32

-2393.77

-1256.01

-1437.39

-2283.48

-1293.62

-1591.53

-2255.76

-1303.80

-1578.93

-2073.71

-1246.63

-1372.47

-2182.76

-1287.39

-1402.15

-2069.73

-1259.14

-1315.87

-2191.10

-1191.51

-1374.80

-3356.65

-169.11

-5698.09

-6211.83

-78.80

-5180.30

-6179.43

-138.96

-5185.61

-6170.37

-137.53

-5227.05

-6210.52

-172.97

-5662.38

-6187.35

-80.01

-5207.88

-6202.53

-175.91

-5226.39

-6198.81

-131.98

-5197.35

-6198.81

-141.92

-2262.30

-1272.56

-1578.04

-2475.58

-1214.13

-1623.82

-2394.07

-1257.52

-1437.41

-2288.25

-1293.69

-1592.17

-2256.41

-1304.71

-1580.02

-2074.38

-1245.92

-1373.64

-2184.01

-1287.59

-1402.55

-2068.48

-1258.40

-1315.73

-2190.89

-1191.79

-1375.23

-3356.91

-169.11

-5698.28

-6212.14

-78.79

-5180.38

-6179.67

-138.83

-5186.16

-6170.92

-137.58

-5227.16

-6210.38

-173.02

-5662.36

-6187.32

-79.90

-5208.04

-6202.66

-175.90

-5226.25

-6198.62

-131.89

-5197.16

-6198.62

-141.73

-2263.18

-1271.90

-1578.58

-2475.74

-1214.54

-1623.89

-2394.17

-1257.71

-1437.81

-2289.32

-1293.90

-1592.72

-2257.39

-1304.94

-1580.42

-2074.91

-1246.39

-1373.85

-2184.47

-1287.43

-1403.14

-2069.05

-1258.80

-1316.19

-2191.60

-1192.45

-1375.10

-3357.00

-169.14

-5698.20

-6212.06

-78.82

-5180.33

-6179.59

-138.83

-5186.18

-6170.86

-137.57

-5227.13

-6210.44

-173.06

-5662.54

-6187.48

-79.94

-5207.92

-6202.51

-175.95

-5226.31

-6198.67

-131.90

-5197.20

-6198.67

-141.68

-2263.61

-1272.08

-1578.92

-2476.01

-1214.45

-1624.12

-2394.69

-1257.74

-1438.00

-2289.43

-1294.00

-1592.91

-2257.90

-1304.97

-1580.79

-2075.25

-1246.32

-1374.09

-2184.56

-1287.38

-1403.31

-2069.16

-1258.67

-1316.44

-2191.65

-1192.67

-1375.28

-3356.89

complexes

RNA

Peptide

1a4t

RNA

Peptide

1biv

RNA

Peptide

1exy

RNA

Peptide

1g70

RNA

Peptide

1hji

RNA

Peptide

1i9f

RNA

Peptide

1mnb

RNA

Peptide

1nyb

RNA

Peptide

1qfq

RNA

Peptide

1ull

RNA

Peptide

1zbn

RNA

Peptide

2a9x

RNA

Peptide

484d

RNA

Peptide

Table 2 – continued from previous page

1.1Å

-5395.60

-2488.46

-1955.33

-3387.87

-1298.94

-5036.97

-9051.16

-1426.81

-7181.42

1.0Å

-5394.74

-2493.11

-1954.40

-3386.84

-1299.11

-5037.82

-9050.71

-1427.04

-7186.36

0.9Å

-5397.30

-2491.86

-1956.66

-3386.67

-1298.86

-5038.24

-9050.75

-1428.76

-7190.43

0.8Å

-5397.28

-2494.41

-1956.34

-3386.19

-1299.20

-5038.68

-9053.86

-1428.92

-7191.02

0.7Å

-5398.59

-2494.39

-1956.86

-3387.95

-1299.21

-5038.36

-9054.29

-1428.93

-7190.72

0.6Å

-5399.35

-2495.30

-1957.32

-3389.01

-1299.88

-5040.25

-9054.94

-1429.21

-7192.47

0.5Å

-5398.91

-2495.44

-1957.42

-3389.22

-1299.72

-5040.11

-9054.65

-1429.35

-7192.83

0.4Å

-5398.86

-2495.62

-1957.66

-3389.36

-1299.80

-5040.33

-9054.89

-1429.39

-7193.12

0.3Å

-5398.95

-2495.82

-1957.71

-3389.26

-1299.80

-5040.56

-9055.18

-1429.44

-7192.74

0.2Å

-5398.90

-2495.81

-1957.71

-3389.32

-1299.77

-5040.61

-9055.14

-1429.43

-7193.16

-11992.99

-11997.02

-12001.64

-12000.27

-12001.98

-12002.02

-12002.88

-12003.06

-12002.90

-12002.94

-1583.96

-7912.40

-1584.68

-7921.74

-1584.12

-7920.12

-1584.21

-7921.19

-1584.61

-7922.57

-1584.53

-7924.05

-1584.64

-7923.84

-1584.73

-7924.19

-1584.71

-7924.17

-1584.75

-7923.96

-11139.81

-11146.74

-11148.00

-11148.48

-11149.92

-11152.11

-11152.09

-11152.87

-11152.77

-11151.78

-814.96

-2031.50

-3353.99

-1206.23

-7643.63

-815.53

-2033.90

-3354.60

-1207.30

-7647.87

-814.10

-2031.70

-3355.37

-1208.07

-7645.77

-814.61

-2032.05

-3356.23

-1208.46

-7646.62

-814.63

-2033.18

-3358.30

-1208.33

-7646.46

-814.94

-2033.13

-3357.88

-1208.45

-7649.27

-814.84

-2033.74

-3358.13

-1208.76

-7649.46

-814.84

-2034.06

-3358.45

-1208.97

-7650.06

-814.89

-2034.36

-3358.51

-1208.96

-7650.19

-814.86

-2034.35

-3358.58

-1208.94

-7650.21

-11298.20

-11300.82

-11298.97

-11301.83

-11302.04

-11304.81

-11305.18

-11305.75

-11305.92

-11305.89

-1243.33

-5174.17

-8885.06

-1190.90

-4809.64

-6783.69

-1072.40

-2034.67

-3353.99

-1215.90

-7312.09

-1242.18

-5179.86

-8893.60

-1190.40

-4812.79

-6786.68

-1074.12

-2039.35

-3354.60

-1221.72

-7314.05

-1241.99

-5181.11

-8892.38

-1191.61

-4815.03

-6787.93

-1074.56

-2043.51

-3355.37

-1221.91

-7316.32

-1243.03

-5180.72

-8891.24

-1191.57

-4814.65

-6788.71

-1074.44

-2039.51

-3356.23

-1220.93

-7317.59

-1242.79

-5180.72

-8892.30

-1191.36

-4815.32

-6789.97

-1075.27

-2041.73

-3358.30

-1221.75

-7318.46

-1242.94

-5180.63

-8891.89

-1191.70

-4816.84

-6789.77

-1075.11

-2042.69

-3357.88

-1221.97

-7318.64

-1242.78

-5181.61

-8893.32

-1191.73

-4817.36

-6790.56

-1075.09

-2040.33

-3358.13

-1221.93

-7318.59

-1242.81

-5181.89

-8893.52

-1191.66

-4817.42

-6790.84

-1075.21

-2042.72

-3358.45

-1222.06

-7319.03

-1242.75

-5181.75

-8893.41

-1191.63

-4817.69

-6791.08

-1075.28

-2043.29

-3358.51

-1222.10

-7318.79

-1242.78

-5181.68

-8893.39

-1191.63

-4817.84

-6791.00

-1075.31

-2043.23

-3358.58

-1222.10

-7318.85

-12974.37

-12970.24

-12977.26

-12978.01

-12980.43

-12978.86

-12979.61

-12979.74

-12979.53

-12979.48

-1787.34

-5170.51

-9137.67

-1661.52

-5813.81

-8892.65

-1022.49

-4462.00

-8754.62

-1687.65

-1788.70

-5173.71

-9139.49

-1660.88

-5815.16

-8891.27

-1023.64

-4467.80

-8760.27

-1687.73

-1787.86

-5171.27

-9137.15

-1662.09

-5816.07

-8891.53

-1025.06

-4462.04

-8756.94

-1689.07

-1788.97

-5173.17

-9138.45

-1662.05

-5819.13

-8894.40

-1025.43

-4463.88

-8757.48

-1689.04

-1789.37

-5172.67

-9137.86

-1662.02

-5818.75

-8893.86

-1025.28

-4463.46

-8756.32

-1689.03

-1789.50

-5173.29

-9139.23

-1662.48

-5819.24

-8894.25

-1025.53

-4465.32

-8758.41

-1689.49

-1789.46

-5173.63

-9139.21

-1662.49

-5819.30

-8894.47

-1025.53

-4464.47

-8758.36

-1689.45

-1789.53

-5173.66

-9139.34

-1662.64

-5819.75

-8894.83

-1025.62

-4464.80

-8758.94

-1689.61

-1789.60

-5173.57

-9139.29

-1662.59

-5819.92

-8895.04

-1025.65

-4465.01

-8759.23

-1689.56

-1789.62

-5173.31

-9138.83

-1662.59

-5819.78

-8894.88

-1025.68

-4464.83

-8759.16

-1689.60

3.2 The inﬂuence of grid spacing in ∆∆Gel estimation

Motivated by well-converged estimations of electrostatic solvation free energies at very coarse grid

spacings as previously discussed, we are interested in predicting the binding free energies for all

RNA-drug, barnase-barstar, and RNA-peptide complexes using our MIBPB package.

11

Figure 2: Electrostatic solvation free energy, for all complexes and unbounded components of
three data sets, with different grid sizes plotted against the one computed with a ﬁnest grid size
of h = 0.2Å. (a) DNA-drug with pair (0.2Å,0.3Å); (b) DNA-drug with pair (0.2Å,0.7Å); (c)
DNA-drug with pair (0.2Å,1.1Å); (d) Barnase-barstar with pair (0.2Å,0.3Å); (e) Barnase-barstar
with pair (0.2Å,0.7Å); (f) Barnase-Barstar with pair (0.2Å,1.1Å); (g) RNA-peptide with pair
(0.2Å,0.3Å); (h) RNA-peptide with pair (0.2Å,0.7Å); (i) RNA-peptide with pair (0.2Å,1.1Å).

Similar to the study of the convergence of ∆Gel, we correlate the binding free energy calculated
at the ﬁnest grid spacing, h = 0.2Å, and ones estimated at coarser mesh sizes, h = 0.3Å,··· ,1.1Å.
Figure 4 illustrates these relationships with the regression lines whose parameters are revealed in

12

Figure 3: Averaged relative absolute error of the electrostatic solvation free energies for all the 153
molecules with mesh size reﬁnements from 1.1Å to 0.2Å.

Table 3. Since the previous discussion conﬁrms MIBPB solver can produce very good R-squared

values even at very coarse grid spacings, it is interesting to explore whether a similar behavior can

be found for binding energy estimation. Indeed, the PB binding energy estimation behaves the

same as the PB solvation calculation in our MIBPB technique. Speciﬁcally, R2 is always 1 at the

ﬁne mesh, h = 0.3Å. Moreover, these values are still satisfactory at relatively coarser mesh sizes.

For example, at the grid spacing of h = 1.1, the R2 and slope of the regression line for DNA-drug,

barnase-barstar, and RNA-peptide complexes are, respectively, (0.9747,1.0081), (0.9965,0.9974),

and (0.9999, 0.9974). In contrast, the R-squared values reported in Ref.,15 computed between

0.3Å and 1.0Å, are unacceptable for SESs, and usually less than 0.62. Our statistical measures

strongly support the reliable binding energy prediction of our solver at coarse grid sizes. Table 4

displays the binding free energy for all complexes with different grid spacings. As can be seen from

Table 4, the difference between binding energies at coarse meshes and the ﬁnest mesh, h = 0.2Å,

is always less than 10 kcal/mol for all complexes.

13

Table 1: R2 values and best ﬁtting lines of electrostatic solvation free energies with different grid
sizes.

DNA-drug

Barnase-barstar

RNA-peptide

Grid sizes (pair)

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

Best ﬁtting line

R2
1.0000 y = 1.0000x− 0.0196
1.0000 y = 1.0000x− 0.0081
1.0000 y = 1.0001x− 0.0621
1.0000 y = 1.0001x− 0.2230
1.0000 y = 1.0003x− 0.2537
1.0000 y = 1.0003x− 0.4161
1.0000 y = 1.0003x− 0.2999
1.0000 y = 1.0005x− 0.0066
1.0000 y = 1.0004x− 0.2485

1.0000 y = 1.0002x + 0.1590
1.0000 y = 1.0005x + 0.3524
1.0000 y = 1.0012x + 0.8735
1.0000 y = 1.0010x− 0.2246
1.0000 y = 1.0017x− 0.3748
1.0000 y = 1.0009x− 0.9576
0.9999 y = 1.0015x + 0.4749
0.9999 y = 0.9986x− 2.9739
0.9997 y = 0.9972x− 4.3801
1.0000 y = 1.0000x− 0.0445
1.0000 y = 1.0000x− 0.1333
1.0000 y = 1.0000x− 0.3343
1.0000 y = 1.0000x− 0.1916
1.0000 y = 1.0001x− 0.5377
1.0000 y = 1.0001x− 0.8198
1.0000 y = 1.0002x− 0.9564
1.0000 y = 1.0003x− 0.8868
1.0000 y = 1.0005x− 2.2504

The trend of binding free energy at different grid spacings can be seen clearly in Figs. 5, 6, and

7 which plot ∆∆Gel against grid sizes varying between 0.2Å and 1.1Å for DNA-drug, barnase-
barstar, and RNA-peptide complexes, respectively. Based on these ﬁgures, our solver can rank the

binding free energy for DNA-drug complexes at grid spacing of 0.6Å, barnase-barstar complexes

at grid spacing of 0.8Å, and RNA-peptide complexes at signiﬁcantly coarse grid spacing of 1.1Å.

Therefore, we can draw a conclusion that the common use of grid size being 0.5Å is still adequate

14

for predicting the binding energy free without producing a misleading result.

Another fact that had led to the pessimistic view in the literature15 towards the PB methodol-

ogy for electrostatic binding energy estimation was the poor correlations between ∆∆Gel computed
based on the SES and those computed with the vdW surface, i.e., R2 = 0.58,0.72, and 0.45, for the

DNA-drug, RNA-peptide and barnase-barstar complexes, respectively. It is believed that different

surface deﬁnitions give rise to different PB parametrizations and their results do not have to be

consistent.3 Nevertheless, in practical applications, each PB parametrization should be appropri-

ately calibrated against experimental data by tuning the PB force ﬁeld parameters, namely, atomic

radii, solvent probe radius, dielectric constants and/or point charges.31

Note that in Table 4, some electrostatic binding free energies obtained in our calculations differ

signiﬁcantly from those reported in Ref.,15 i.e., more than 50 kcal/mol at the ﬁnest grid spacing,

under the same parametrization and data inputs. For this reason, we have employed PBSA, Delphi,

and APBS at the grid size of 0.2 Å to conﬁrm our estimations as mentioned above.

4 Conclusions

Poisson-Boltzmann (PB) theory is an established model for biomolecular electrostatic analysis

and has been widely used in electrostatic solvation ∆Gel and binding energy ∆∆Gel estimations.
However, doubt has been cast on the validity of the commonly used grid spacing of 0.5 Å for

producing converged estimates of ∆∆Gel due to the unacceptable errors observed in the calcula-
tion using the solvent excluded surface (SES) and the adaptive Cartesian grid (ACG) ﬁnite differ-

ence PB equation solver.15 Three sets of biomolecular complexes, namely, DNA-drug complexes,

barnase-barstar complexes, and RNA-peptide complexes, are employed in the study. The discrep-

ancies between results obtained from different surface deﬁnitions were also utilized to support the

general pessimism for the PB methodology.

In this work, we employ the MIBPB software16,17,24 to estimate electrostatic solvation free

energy, ∆Gel, and binding free electrostatic energy, ∆∆Gel, for the three sets of biomolecular com-

15

Figure 4: Electrostatic binding free energy, for all complexes with different grid sizes plotted
against the one computed with a ﬁnest grid size of h = 0.2Å. (a) DNA-drug with pair (0.2Å,0.3Å);
(b) DNA-drug with pair (0.2Å,0.7Å); (c) DNA-drug with pair (0.2Å,1.1Å); (d) Barnase-barstar
with pair (0.2Å,0.3Å); (e) Barnase-barstar with pair (0.2Å,0.7Å); (f) Barnase-barstar with pair
(0.2Å,1.1Å); (g) RNA-peptide with pair (0.2Å,0.3Å); (h) RNA-peptide with pair (0.2Å,0.7Å);
(i) RNA-peptide with pair (0.2Å,1.1Å).

plexes used in Ref.15 The popular SES is adopted in the present work. In our ∆Gel estimation, the
averaged relative absolute error computed at a relatively coarse grid size of 1.1Å against the ﬁnest

16

Table 3: R2 values and best ﬁtting lines of electrostatic binding free energies with different grid
sizes.

Grid sizes (pair)

R2

Best ﬁtting line

DNA-drug

Barnase-barstar

RNA-peptide

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

(0.2,0.3)
(0.2,0.4)
(0.2,0.5)
(0.2,0.6)
(0.2,0.7)
(0.2,0.8)
(0.2,0.9)
(0.2,1.0)
(0.2,1.1)

1.0000 y = 0.9993x + 0.0194
0.9999 y = 0.9987x + 0.0273
0.9998 y = 1.0028x + 0.0164
0.9991 y = 1.0047x + 0.2256
0.9982 y = 1.0074x + 0.1394
0.9966 y = 1.0110x + 0.1484
0.9906 y = 0.9655x + 1.2385
0.9875 y = 0.9827x + 0.5894
0.9747 y = 1.0081x + 0.0709
1.0000 y = 0.9998x− 0.0685
1.0000 y = 0.9999x− 0.0866
0.9999 y = 1.0002x− 0.1815
0.9999 y = 0.9997x + 0.2314
0.9999 y = 1.0003x− 0.0592
0.9998 y = 1.0010x + 0.5930
0.9992 y = 1.0016x + 1.1027
0.9992 y = 1.0022x + 1.8956
0.9965 y = 0.9974x + 1.5157
1.0000 y = 0.9998x− 0.0685
1.0000 y = 0.9999x− 0.0866
1.0000 y = 1.0002x− 0.1815
1.0000 y = 0.9997x + 0.2314
1.0000 y = 1.0003x− 0.0592
1.0000 y = 1.0010x + 0.5930
0.9999 y = 1.0016x + 1.1027
0.9999 y = 1.0022x + 1.8956
0.9999 y = 0.9974x + 1.5157

grid size of 0.2 Å over 153 studied biomolecules is less than 0.31%. The same error obtained at

the grid size of 1.0Å is less than 0.2%. These results indicate the reliability of using the MIBPB

solver at the grid spacing of 1.0Å or even 1.1Å for electrostatic solvation analysis. The robustness

and accuracy of MIBPB solver for estimates of ∆Gel have been reported for 24 proteins in the
literature.16,24 This characteristics has been conﬁrmed again in the present work for DNA-drug

complexes, barnase-barstar complexes, and RNA-peptide complexes.

17

Table 4: Electrostatic binding free energies (in units of kcal/mol), ∆∆Gel, for all of the complexes
used in this study at different grid sizes.

complexes

1.1Å

1.0Å

0.9Å

0.8Å

0.7Å

0.6Å

0.5Å

0.4Å

0.3Å

0.2Å

DNA-drug

Barnase-barstar

RNA-peptide

102d
109d
121d
127d
129d
166d
195d
1d30
1d63
1d64
1d86
1dne
1eel
1fmq
1fms
1jtl
1lex
1prp
227d
261d
264d
289d
298d
2dbe
302d
311d
328d
360d
1b27
1b2s
1b2u
1b3s
1x1u*
1x1w
1x1x*
1x1y
2za4
1a1t*
1a4t*
1biv*
1exy*
1g70
1hji*
1i9f*
1mnb*
1nyb
1qfq*
1ull*
1zbn*
2a9x*
484d*

9.45
3.61
23.95
27.60
37.58
15.04
2.74
11.27
15.51
14.98
27.37
22.26
16.71
12.35
27.08
11.62
13.47
11.30
6.28
1.91
33.64
15.32
11.65
3.48
23.28
11.76
14.25
54.41
86.80
67.80
85.97
48.41
397.85
90.62
413.32
67.27
74.13
62.24
506.33
41.80
178.36
176.17
-26.31
421.11
-376.84
27.85
-1.60
423.06
206.77
-89.16
129.72

10.50
2.18
23.99
28.80
40.23
16.60
3.73
10.01
12.83
14.11
25.53
22.73
17.06
13.40
26.14
10.99
10.37
11.93
4.79
3.00
32.35
15.71
15.94
5.06
25.22
3.36
16.21
54.72
83.08
66.33
76.39
56.58
402.96
87.91
407.93
88.13
70.86
58.24
506.40
40.73
178.17
174.33
-27.03
418.34
-374.49
29.41
0.15
418.33
204.75
-90.74
129.65

8.73
2.30
23.80
28.45
39.92
13.97
2.80
10.71
7.08
14.26
24.50
22.32
14.94
14.28
25.17
11.80
9.79
10.78
5.96
1.75
31.57
17.94
14.81
3.49
24.91
7.15
17.38
56.63
95.40
68.81
74.78
49.61
410.63
99.13
407.98
89.80
70.64
61.71
503.72
42.07
178.16
175.78
-23.29
418.40
-375.75
28.86
-3.05
422.24
206.06
-89.97
133.42

10.01
3.72
24.05
28.89
39.03
14.93
2.63
9.31
12.56
14.03
25.88
22.92
14.82
14.72
24.52
11.47
9.44
10.88
3.79
1.55
30.83
16.70
15.89
6.14
25.49
9.72
17.85
54.59
82.48
71.75
78.29
46.02
411.17
93.67
409.72
90.39
69.80
61.89
503.90
44.90
176.29
175.70
-22.39
421.45
-376.54
29.90
0.83
422.83
205.42
-89.79
132.09

10.21
2.63
22.84
28.88
39.52
14.91
2.77
10.26
12.07
14.86
25.04
22.48
14.77
15.27
25.41
11.30
8.74
11.01
5.47
2.60
32.09
16.57
14.87
5.51
24.95
11.12
16.79
55.38
87.05
70.03
75.29
49.87
413.66
94.65
411.04
87.87
72.45
62.94
505.15
45.66
178.70
175.78
-21.58
421.58
-375.69
31.32
1.50
424.78
205.30
-90.10
131.34

10.76
2.07
23.65
28.93
39.90
15.49
2.77
10.12
11.24
14.24
25.57
22.62
14.60
15.09
25.93
11.28
9.74
11.55
5.16
2.79
31.97
16.21
14.88
5.77
25.00
8.17
17.14
54.56
89.40
71.47
77.35
48.17
412.66
93.55
411.98
87.24
73.22
63.18
506.42
44.70
176.91
176.80
-21.83
421.69
-375.67
29.44
0.34
423.16
206.51
-89.95
132.03

10.53
2.66
24.10
29.27
40.04
15.47
2.63
10.40
12.10
14.51
25.39
22.58
15.08
15.30
25.82
11.37
9.81
11.55
5.80
2.97
32.07
16.22
15.38
5.76
24.87
8.98
17.84
55.44
87.35
72.32
77.15
53.44
411.16
95.53
412.83
88.54
73.26
62.88
506.37
44.69
177.52
176.89
-21.88
421.71
-375.19
29.69
2.91
423.92
206.16
-89.79
132.79

10.45
2.69
23.94
29.16
40.15
15.62
2.69
10.75
12.29
14.57
25.44
22.74
14.85
15.36
25.75
11.28
9.70
11.49
5.75
2.76
32.20
16.56
15.45
5.88
25.29
9.34
17.68
55.80
87.96
71.93
78.38
49.38
412.51
95.32
412.18
88.91
74.18
62.75
506.35
44.75
177.50
177.32
-21.67
421.71
-375.34
30.03
0.97
423.68
206.41
-89.79
133.20

10.34
2.82
23.96
29.12
40.20
15.67
2.72
10.53
12.34
14.59
25.50
22.83
15.15
15.36
25.71
11.41
9.70
11.61
5.46
2.80
32.31
16.59
15.50
5.68
25.17
9.30
17.54
55.61
86.96
72.25
78.87
49.07
412.16
95.47
412.15
89.20
74.00
62.95
506.20
44.86
177.70
177.29
-21.92
421.69
-375.34
30.07
0.50
423.78
206.40
-89.72
133.23

10.31
2.72
23.93
29.12
40.24
15.67
2.73
10.59
12.39
14.58
25.54
22.81
15.07
15.37
25.74
11.45
9.70
11.61
5.58
2.85
32.34
16.56
15.41
5.81
25.19
9.32
17.54
55.57
87.05
72.12
78.57
49.25
412.05
95.30
412.18
89.21
74.35
63.00
506.23
44.76
177.36
176.48
-21.86
421.67
-375.29
29.87
0.63
423.69
206.20
-89.71
133.38

* Results are signiﬁcantly different (>50 kcal/mol) from those in Ref. 15

The well-converged ∆Gel produced by our solver enables a promising performance in predict-
ing ∆∆Gel at a coarse grid spacing. Indeed, numerical estimates of ∆∆Gel in the current work
reveals that ∆∆Gel obtained at a 1.1Å grid spacing mostly differ by less than 10 kcal/mol from

18

Figure 5: Binding electrostatic energy for DNA-drug complexes with grid sizes from 0.2Å to
1.1Å. The markers and PDBIDs are as follows yellow circle : 102d, magenta circle : 109d, cyan
circle : 121d, green circle : 127d, red circle : 129d, blue circle : 166d, black circle : 195d, yellow
diamond : 1d30, magenta diamond : 1d63, cyan diamond : 1d64, green diamond : 1d86, red
diamond : 1dne, blue diamond : 1eel, black diamond : 1fmq, yellow square : 1fms, magenta
square : 1jtl, cyan square : 1lex, green square : 1prp, red square : 227d, blue square : 261d, black
square : 264d, yellow triangle: 289d, magenta triangle: 298d, cyan triangle: 2dbe, green triangle:
302d, red triangle: 311d, blue triangle: 328d, black triangle: 360d.

Figure 6: Binding electrostatic energy for barnase-barstar complexes with grid sizes from 0.2Å to
1.1Å. The markers and PDBIDs are as follows yellow circle : 1b27, magenta circle : 1b2s, cyan
circle : 1b2u, green circle : 1b3s, red circle : 1x1u, blue circle : 1x1w, black circle : 1x1x, yellow
diamond: 1x1y, magenta diamond: 2za4.

that achieved by using a 0.2Å grid spacing. Moreover, MIBPB solver conducted at grid size of

0.6Å perfectly produces a well-converged ∆∆Gel, and qualitatively ranks the complexes in term

19

Figure 7: Binding electrostatic energy for RNA-peptide complexes with grid sizes from 0.2Å to
1.1Å. The markers and PDBIDs are as follows yellow circle : 1a1t, magenta circle : 1a4t, cyan
circle : 1biv, green circle : 1exy, red circle : 1g70, blue circle : 1hji, black circle : 1i9f, yellow
diamond : 1mnb, magenta diamond : 1nyb, cyan diamond : 1qfq, red diamond : 1ull, green
diamond : 1zbn, blue diamond : 2a9x, black diamond : 484d.

of their binding free energies. Therefore, the current results support an opinion that the widely

used grid size of 0.5Å can give reliable and accurate enough predictions of both electrostatic free

energy32,33 and binding free energy.

Finally, we believe that it is inappropriate to draw a conclusion about the validity of the PB

methodology from the discrepancies in ∆Gel and/or ∆∆Gel estimations obtained from different
surface deﬁnitions.

Acknowledgement

This work was supported in part by NSF Grant Nos. IIS- 1302285 and DMS-1160352, NIH Grant

No. R01GM-090208 and MSU Center for Mathematical Molecular Biosciences Initiative. DDN

and GWW thank the Mathematical Biosciences Institute for its hospitality and support during their

visit in Ohio State University, where this manuscript was ﬁnalized. This manuscript was reviewed

by Professors Emil Alexov and Ray Luo prior its submission.

20

Appendix A The Coulomb binding free energies

Table 5: The Coulomb binding free energies (in units of kcal/mol) of three systems in vacuum.

DNA-drug complexes

PDB ID Energy
-1146.38
102d
-623.81
109d
-1155.31
121d
127d
-580.27
-585.17
129d
-1121.25
166d
195d
-1156.25

PDB ID Energy
-1150.05
1d30
-1156.88
1d63
-1119.99
1d64
1d86
-1162.02
-1171.15
1dne
-1121.02
1eel
1fmq
-1110.26

PDB ID Energy
-1124.88
1fms
-509.55
1jtl
-1162.97
1lex
1prp
-1139.46
-1161.99
227d
-1011.43
261d
264d
-560.34

PDB ID Energy
-1121.53
289d
-1106.84
298d
-1150.56
2dbe
302d
-579.69
-1161.22
311d
-1086.72
328d
360d
-1087.58

Barnase-barstar complexes

PDB ID Energy
-500.34
1b27
1b2s
-290.44

PDB ID Energy
-222.48
1b2u
1b3s
-548.23

PDB ID Energy
-215.81
1x1u
1x1w
-449.86

PDB ID Energy
-93.95
1x1x
-416.74
1x1y
2za4
-301.95

RNA-peptide complexes

PDB ID Energy
1a1t
-4474.82
-2225.15
1a4t
1biv
-5399.20

PDB ID Energy
1exy
-6217.17
-3866.20
1g70
1hji
-2555.03

PDB ID Energy
1i9f
-4476.79
-5278.63
1mnb
-3018.60
1nyb
1qfq
-2536.82

PDB ID Energy
1ull
-7026.56
-5421.91
1zbn
-4190.49
2a9x
484d
-5850.55

21

References

(1) Gilson, M. K.; Sharp, K.; Honig, B. Calculating the Electrostatic Potential of Molecules in

Solution: Method and error assessment. J. Comp. Chem. 1987, 9, 327–335.

(2) Gilson, M. K.; Davis, M. E.; Luty, B. A.; McCammon, J. A. Computation of electrostatic

forces on solvated molecules using the Poisson-Boltzmann equation. Journal of Physical

Chemistry 1993, 97, 3591–3600.

(3) Talley, K.; Ng, C.; Shoppell, M.; Kundrotas, P.; Alexov, E. On the electrostatic component of

protein-protein binding free energy. PMC Biophysics 2008, 1:2, 1–23.

(4) Zhou, Y. C.; Feig, M.; Wei, G. W. Highly accurate biomolecular electrostatics in continuum

dielectric environments. Journal of Computational Chemistry 2008, 29, 87–97.

(5) Ren, P.; Chun, J.; Thomas, D. G.; Schnieders, M. J.; Marucho, M.; Zhang, J.; Baker, N. A.

Biomolecular electrostatics and solvation: a computational perspective. Quarterly reviews of

biophysics 2012, 45(04), 427–491.

(6) Jo, S.; Vargyas, M.; Vasko-Szedlar, J.; Roux, B.; Im, W. PBEQ-Solver for online visualization

of electrostatic potential of biomolecules. Nucleic Acids Research 2008, 36, W270 –W275.

(7) Baker, N. A.; Sept, D.; Holst, M. J.; Mccammon, J. A. The adaptive multilevel ﬁnite element

solution of the Poisson-Boltzmann equation on massively parallel computers. IBM Journal

of Research and Development 2001, 45, 427–438.

(8) Geng, W. H.; Krasny, R. A treecode-accelerated boundary integral Poisson-Boltzmann solver

for continuum electrostatics of solvated biomolecules. J. Comput. Phys. 2013, 247, 62–87.

(9) Lu, B.; Cheng, X.; Huang, J.; McCammon, J. A. AFMPB: An Adaptive Fast Multipole

Poisson-Boltzmann Solver for Calculating Electrostatics in Biomolecular Systems. Comput.

Phys. Commun. 2013, 184, 2618–2619.

22

(10) Wang, J.; Tan, C. H.; Tan, Y. H.; Lu, Q.; Luo, R. Poisson-Boltzmann solvents in molecular

dynamics Simulations. Communications in Computational Physics 2008, 3(5), 1010–1031.

(11) Cai, Q.; Hsieh, M. J.; Wang, J.; Luo, R. Performance of Nonlinear Finite-Difference Poisson-

Boltzmann Solvers. Journal of Chemical Theory and Computation 2009, 6(1), 203–211.

(12) Li, L.; Li, C.; Sarkar, S.; Zhang, J.; Witham, S.; Zhang, Z.; Wang, L.; Smith, N.; Petukh, M.;

Alexov, E. Delphi: a comprehensive suite for Delphi software and associated resources. BMC

Biophysics 2012, 5:9, 2046–1682.

(13) Rocchia, W.; Sridharan, S.; Nicholls, A.; Alexov, E.; Chiabrera, A.; Honig, B. Rapid grid-

based construction of the molecular surface and the use of induced surface charge to calculate

reaction ﬁeld energies: Applications to the molecular systems and geometric objects. Journal

of Computational Chemistry 2002, 23, 128 – 137.

(14) Baker, N. A.; Sept, D.; Joseph, S.; Holst, M. J.; McCammon, J. A. Electrostatics of nanosys-

tems: Application to microtubules and the ribosome. Proceedings of the National Academy

of Sciences of the United States of America 2001, 98, 10037–10041.

(15) Harris, R. C.; Boschitsch, A. H.; Fenley, M. O. Inﬂuence of Grid Spacing in Poisson-

Boltzmann Equation Binding Energy Estimation. Journal of Chemical Theory and Computa-

tion 2013, 9, 3677–3685.

(16) Chen, D.; Chen, Z.; Chen, C.; Geng, W. H.; Wei, G. W. MIBPB: A software package for

electrostatic analysis. J. Comput. Chem. 2011, 32, 657 – 670.

(17) Wang, B.; Nguyen, D. D.; Zhao, Z.; Cang, Z.; Wei, G.-W. MIBPB: An accurate and reliable

software package for electrostatic analysis. Preprint 2015,

(18) Richards, F. M. Areas, Volumes, Packing, and Protein Structure. Annual Review of Biophysics

and Bioengineering 1977, 6, 151–176.

23

(19) Connolly, M. L. Analytical molecular surface calculation. Journal of Applied Crystallogra-

phy 1983, 16, 548–558.

(20) Sanner, M. F.; Olson, A. J.; Spehner, J. C. Reduced surface: An efﬁcient way to compute

molecular surfaces. Biopolymers 1996, 38, 305–320.

(21) Zhou, Y. C.; Zhao, S.; Feig, M.; Wei, G. W. High order matched interface and boundary

method for elliptic equations with discontinuous coefﬁcients and singular sources. J. Comput.

Phys. 2006, 213, 1–30.

(22) Yu, S. N.; Geng, W. H.; Wei, G. W. Treatment of geometric singularities in implicit solvent

models. Journal of Chemical Physics 2007, 126, 244108.

(23) Yu, S. N.; Wei, G. W. Three-dimensional matched interface and boundary (MIB) method for

treating geometric singularities. J. Comput. Phys. 2007, 227, 602–632.

(24) Geng, W.; Yu, S.; Wei, G. W. Treatment of charge singularities in implicit solvent models.

Journal of Chemical Physics 2007, 127, 114106.

(25) Decherchi, S.; Rocchia, W. A general and robust ray-casting-based algorithm for triangulating

surfaces at the nanoscale. PLoS ONE 2013, 8, e59744.

(26) Liu, B.; Wang, B.; Zhao, R.; Tong, Y.; Wei, G. W. ESES: software for Eulerian solvent

excluded surface. Preprint 2015,

(27) Harris, R. C.; Bredenberg, J. H.; Silalahi, A. R. J.; Boschitsch, A. H.; Fenley, M. O. Under-

standing the physical basis of the salt dependence of the electrostatic binding free energy of

mutated charged ligand-nucleic acid complexes. Biophysical Chemistry 2011, 156, 79–87.

(28) Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.;

Ferrin, T. E. UCSF Chimera–a visualization system for exploratory research and analysis. J.

Comput. Chem. 2004, 25, 1605–1612.

24

(29) Feig, M.; Onufriev, A.; Lee, M. S.; Im, W.; Case, D. A.; Brooks, I., C. L. Performance com-

parison of generalized Born and Poisson methods in the calculation of electrostatic solvation

energies for protein structures. Journal of Computational Chemistry 2004, 25, 265–284.

(30) Reyes, C. M.; Kollman, P. A. Structure and thermodynamics of RNA-protein binding: using

molecular dynamics and free energy analyses to calculate the free energies of binding and

conformational change. Journal of molecular biology 2000, 297, 1145–1158.

(31) Chen, Z.; Baker, N. A.; Wei, G. W. Differential geometry based solvation models I: Eulerian

formulation. J. Comput. Phys. 2010, 229, 8231–8258.

(32) Nicholls, A.; Mobley, D. L.; Guthrie, J. P.; Chodera, J. D.; Bayly, C. I.; Cooper, M. D.;

Pande, V. S. Predicting small-molecule solvation free energies: an informal blind test for

computational chemistry. Journal of Medicinal Chemistry 2008, 51, 769–779.

(33) Shivakumar, D.; Williams, J.; Wu, Y.; Damm, W.; Shelley, J.; Sherman, W. Prediction of

absolute solvation free energies using molecular dynamics free energy perturbation and the

OPLS force ﬁeld. Journal of Chemical Theory and Computation 2010, 6, 1509–1519.

25

